chr11:101029624:> Detail (hg38)

Information

Genome

Assembly Position
hg19 chr11:100,900,355-101,000,544 
hg38 chr11:101,029,624-101,129,813

HGVS

Type Transcript Protein
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

[No Data.]

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score Disease name Description Source Pubmed Links
<0.001 squamous cell carcinoma NA BeFree Detail
0.003 carpal tunnel syndrome NA LHGDN Detail
<0.001 Charcot-Marie-Tooth disease NA BeFree Detail
<0.001 chordoma NA BeFree Detail
0.003 choriocarcinoma NA LHGDN Detail
<0.001 colorectal carcinoma NA BeFree Detail
0.003 Colorectal Neoplasms NA LHGDN Detail
0.002 Connective Tissue Diseases NA GAD Detail
<0.001 craniopharyngioma NA BeFree Detail
<0.001 Cyst NA BeFree Detail
<0.001 diabetes insipidus NA BeFree Detail
0.002 Endocrine System Diseases NA GAD Detail
0.151 Endometrial Neoplasms NA CTD_human,GAD,LHGDN Detail
<0.001 endometrial hyperplasia NA BeFree Detail
0.248 endometriosis CRISPLD2 is a target of progesterone receptor and its expression is decreased in... BeFree,CTD_human,GAD,LHGDN,RGD 24955763 Detail
0.248 endometriosis Decreased expression of mucin-1 in endometriosis endometrium correlated with pro... BeFree,CTD_human,GAD,LHGDN,RGD 25155819 Detail
0.248 endometriosis Our results suggest that DNG exerts therapeutic efficacy against the pain and pr... BeFree,CTD_human,GAD,LHGDN,RGD 25533385 Detail
0.248 endometriosis Dienogest (DNG), a selective progesterone receptor agonist, is widely used to tr... BeFree,CTD_human,GAD,LHGDN,RGD 25767055 Detail
0.002 Fetal Diseases NA GAD Detail
<0.001 Psychosexual identity disorder NA BeFree Detail
<0.001 glioblastoma NA BeFree Detail
0.080 breast carcinoma We did not observe an association between potential functional genetic polymorph... BeFree 23935996 Detail
<0.001 gonadal dysgenesis NA BeFree Detail
0.003 granulosa cell tumor NA LHGDN Detail
<0.001 cardiac arrest ECCCs had SCA-like features with rare expression of estrogen receptor/progestero... BeFree 25473756 Detail
0.132 Malignant neoplasm of breast We did not observe an association between potential functional genetic polymorph... BeFree 23935996 Detail
0.007 Female infertility NA GAD Detail
<0.001 Mammary Ductal Carcinoma NA BeFree Detail
0.007 Inflammation NA GAD,LHGDN Detail
<0.001 Kidney Neoplasm NA BeFree Detail
0.003 Premature Obstetric Labor NA LHGDN Detail
0.024 Fibroid Tumor NA BeFree,GAD,LHGDN Detail
<0.001 leukemia NA BeFree Detail
<0.001 Leukemia, Myelocytic, Acute NA BeFree Detail
0.002 Chronic Obstructive Airway Disease NA GAD Detail
<0.001 Lymphatic Metastasis NA BeFree Detail
0.002 Lymphoma, Non-Hodgkin NA GAD Detail
<0.001 Malignant neoplasm of stomach NA BeFree Detail
0.122 Animal Mammary Neoplasms NA CTD_human,GAD Detail
0.120 Mammary Neoplasms, Experimental NA CTD_human Detail
0.003 melanoma NA BeFree,LHGDN Detail
<0.001 Chloasma Nuclear histological expression for ER-β was associated to sun-induced melasma a... BeFree 25439299 Detail
0.126 meningioma NA BeFree,CTD_human,LHGDN Detail
0.120 Mesothelioma NA CTD_human Detail
0.003 Metaplasia NA LHGDN Detail
0.002 Musculoskeletal Diseases NA GAD Detail
<0.001 myoma NA BeFree Detail
0.005 Neoplasm Metastasis MTDH overexpression was significantly associated with a high nuclear grade, nega... BeFree 22903204 Detail
0.005 Neoplasm Metastasis Triple-negative breast cancer (TNBC) is a distinct breast cancer subtype defined... BeFree 24786829 Detail
0.005 Neoplasm Metastasis In breast cancer, PR becomes highly correlated with ER, and this convergence is ... BeFree 25261374 Detail
<0.001 nephroblastoma NA BeFree Detail
<0.001 neurofibroma NA BeFree Detail
0.003 obesity NA BeFree,GAD Detail
<0.001 oligospermia NA BeFree Detail
0.002 osteoporosis NA GAD Detail
0.011 ovarian carcinoma Importantly, this BTB mediated inhibition of ER activity is selective since BTB ... BeFree,GAD 25221777 Detail
<0.001 Ovarian Diseases NA BeFree Detail
<0.001 Pain Our results suggest that DNG exerts therapeutic efficacy against the pain and pr... BeFree 25533385 Detail
0.005 panic disorder NA BeFree,GAD,LHGDN Detail
<0.001 paraganglioma Additionally, confirmation of immunoreactivity for progesterone receptor and pan... BeFree 25886293 Detail
0.085 polycystic ovary syndrome NA BeFree,GAD,RGD Detail
<0.001 polyps NA BeFree Detail
0.002 Pregnancy Complications, Hematologic NA GAD Detail
0.003 Prostatic Neoplasms NA BeFree,LHGDN Detail
0.002 proteinuria NA GAD Detail
<0.001 Tension Headache NA BeFree Detail
0.002 Delayed puberty NA GAD Detail
0.002 Precocious Puberty NA GAD Detail
<0.001 Seizures NA BeFree Detail
<0.001 seminoma NA BeFree Detail
0.002 Dermatologic disorders NA GAD Detail
<0.001 Thromboembolism NA BeFree Detail
0.005 Tobacco use disorder NA GAD Detail
<0.001 Turner syndrome NA BeFree Detail
0.003 Uterine Diseases NA BeFree,GAD Detail
0.008 Uterine Fibroids NA BeFree Detail
0.005 Uterine Neoplasms NA GAD Detail
0.002 Uterine Prolapse NA GAD Detail
<0.001 Vertigo NA BeFree Detail
0.003 B-Cell Lymphomas NA BeFree,LHGDN Detail
0.002 Ovarian Failure, Premature NA GAD Detail
<0.001 hepatitis E NA BeFree Detail
0.006 Migraine Disorders Progesterone receptor gene (PROGINS) polymorphism correlates with late onset of ... BeFree,GAD 25494303 Detail
0.017 Premature Birth NA GAD Detail
<0.001 Malignant neoplasm of gallbladder NA BeFree Detail
<0.001 uterine cancer NA BeFree Detail
<0.001 endometriosis of ovary NA BeFree Detail
<0.001 Aortic Aneurysm, Abdominal NA BeFree Detail
<0.001 Russell-Silver syndrome NA BeFree Detail
<0.001 Agenesis of corpus callosum NA BeFree Detail
0.001 Tumor Progression In univariate analyses, high tumor cell density (p = 0.006) and high tumor strom... BeFree 25723513 Detail
<0.001 Adenocarcinoma, Tubular NA BeFree Detail
<0.001 endometrial stromal sarcoma NA BeFree Detail
0.003 leiomyomatosis NA LHGDN Detail
0.003 adrenal cortical adenoma NA BeFree,LHGDN Detail
<0.001 adrenocortical carcinoma NA BeFree Detail
0.001 Carcinoma, Endometrioid Expression of OLFM4 was increased during endometrial carcinogenesis, linked to t... BeFree 24495253 Detail
0.001 Carcinoma, Endometrioid ECCCs had SCA-like features with rare expression of estrogen receptor/progestero... BeFree 25473756 Detail
<0.001 Cystadenocarcinoma, Serous NA BeFree Detail
<0.001 Cervical Intraepithelial Neoplasia NA BeFree Detail
<0.001 Nerve Sheath Tumors NA BeFree Detail
0.003 Neuroendocrine Tumors Additionally, confirmation of immunoreactivity for progesterone receptor and pan... BeFree,LHGDN 25886293 Detail
<0.001 Comedone NA BeFree Detail
<0.001 Malignant neoplasm of female breast NA BeFree Detail
<0.001 gallbladder carcinoma NA BeFree Detail
<0.001 pancreatic carcinoma NA BeFree Detail
<0.001 Carcinoma of male breast NA BeFree Detail
<0.001 Papillary thyroid carcinoma Impact of estrogen and progesterone receptor expression on the clinical and mole... BeFree 25862786 Detail
0.002 Erectile dysfunction NA GAD Detail
0.004 Malignant neoplasm of lung NA BeFree,GAD Detail
<0.001 Malignant neoplasm of male breast NA BeFree Detail
<0.001 Impaired glucose tolerance This phenomenon is regulated through an interaction between SMTNL1 and progester... BeFree 26048986 Detail
<0.001 Stage III Breast Cancer AJCC v6 NA BeFree Detail
0.001 Carcinoma breast stage IV NA BeFree Detail
0.001 inflammatory breast carcinoma NA BeFree Detail
<0.001 Recurrent Endometrial Cancer NA BeFree Detail
<0.001 Lobular carcinoma in situ of breast NA BeFree Detail
<0.001 Invasive lobular breast carcinoma PLC was associated more closely with in situ carcinoma (P = .03), and had lower ... BeFree 25682191 Detail
0.003 Adenocarcinoma Of Esophagus NA BeFree,GAD Detail
<0.001 cervical adenocarcinoma NA BeFree Detail
<0.001 Non-infiltrating lobular carcinoma NA BeFree Detail
<0.001 anaplastic astrocytoma NA BeFree Detail
<0.001 endometriosis of uterus NA BeFree Detail
<0.001 Breast Cancer, Familial NA BeFree Detail
<0.001 Atypical endometrial hyperplasia NA BeFree Detail
<0.001 Pulmonary lymphangioleiomyomatosis NA BeFree Detail
0.011 Malignant neoplasm of prostate High progesterone receptor expression in prostate cancer is associated with clin... BeFree,GAD 25723513 Detail
0.002 thrombophilia NA GAD Detail
0.018 endometrial carcinoma Association of the +331G/A progesterone receptor gene (PgR) polymorphism with ri... BeFree,GAD 25037596 Detail
0.018 endometrial carcinoma Systematic dissection of the mechanisms underlying progesterone receptor downreg... BeFree,GAD 25229191 Detail
0.018 endometrial carcinoma A lentiviral-based shRNA knockdown approach was used to generate stable PGRMC1-i... BeFree,GAD 25304370 Detail
<0.001 Overweight NA BeFree Detail
0.002 Hematocrit level NA GAD Detail
0.080 breast carcinoma Glyoxalase I Ala111Glu gene polymorphism: No association with breast cancer risk... BeFree 20712647 Detail
0.132 Malignant neoplasm of breast Glyoxalase I Ala111Glu gene polymorphism: No association with breast cancer risk... BeFree 20712647 Detail
0.003 Carcinogenesis Progesterone, acting through its receptor, PR (progesterone receptor), is the na... BeFree 25229191 Detail
<0.001 Tumor Initiation Loss of miR-141 enhanced both mammosphere formation and tumor initiation. miR-14... BeFree 25241899 Detail
0.002 prostate carcinoma High progesterone receptor expression in prostate cancer is associated with clin... BeFree 25723513 Detail
<0.001 Hashimoto Disease NA BeFree Detail
0.008 Epithelial ovarian cancer NA BeFree,GAD Detail
<0.001 Progressive Neoplastic Disease NA BeFree Detail
0.001 Carcinoma of lung NA BeFree Detail
0.008 Secondary malignant neoplasm of lymph node The overall analysis showed that higher expression of ALDH1A1 is associated with... BeFree 24938375 Detail
0.008 Secondary malignant neoplasm of lymph node In addition, significant associations were also observed between TNFRSF1A polymo... BeFree 25010932 Detail
0.008 Secondary malignant neoplasm of lymph node LOH in THRB was associated with negative estrogen receptor (ER), negative proges... BeFree 26350179 Detail
0.002 Pregnancy loss NA GAD Detail
<0.001 stomach carcinoma NA BeFree Detail
<0.001 Malignant Female Reproductive System Neoplasm NA BeFree Detail
<0.001 early pregnancy NA BeFree Detail
<0.001 Stage I Endometrial Carcinoma NA BeFree Detail
0.002 Pregnancy associated hypertension NA GAD Detail
0.003 Invasive breast carcinoma Higher miR-21 expression in invasive breast carcinomas is associated with positi... BeFree 24781337 Detail
0.003 Invasive breast carcinoma Aberrant events and increased variation in imprinted gene DNA methylation, there... BeFree 25560175 Detail
<0.001 placental choriocarcinoma NA BeFree Detail
<0.001 Stromal Neoplasm In univariate analyses, high tumor cell density (p = 0.006) and high tumor strom... BeFree 25723513 Detail
0.008 ovarian neoplasm NA BeFree,GAD,LHGDN Detail
<0.001 Contralateral breast cancer NA BeFree Detail
0.002 Invasive Ductal Breast Carcinoma We analyzed the changes in mitochondrial DNA (mtDNA) copy numbers and the shifti... BeFree 25845386 Detail
0.028 Malignant neoplasm of ovary Importantly, this BTB mediated inhibition of ER activity is selective since BTB ... BeFree,GAD 25221777 Detail
0.002 endometrial adenocarcinoma NA BeFree Detail
0.001 Ductal Carcinoma Cyclin D1 expression was seen in 67.5% of ductal carcinoma and it showed a signi... BeFree 25313758 Detail
<0.001 Benign cystic nephroma NA BeFree Detail
<0.001 Atypical Ductal Breast Hyperplasia NA BeFree Detail
<0.001 Primary Carcinoma NA BeFree Detail
0.001 Sporadic Breast Carcinoma NA BeFree Detail
<0.001 Well Differentiated Pancreatic Endocrine Tumor Our study showed that PanNETs with favorable prognostic features have higher ERβ... BeFree 25058880 Detail
<0.001 Metastatic Carcinoma NA BeFree Detail
<0.001 Cardiomyopathy, Familial Idiopathic NA BeFree Detail
0.208 Mammary Neoplasms A model of spontaneous mouse mammary tumor for human estrogen receptor- and prog... BeFree,CTD_human,GAD,LHGDN 25230850 Detail
0.208 Mammary Neoplasms Progesterone receptor activation downregulates GATA3 by transcriptional repressi... BeFree,CTD_human,GAD,LHGDN 25479686 Detail
0.208 Mammary Neoplasms Positive immunostaining for USP2 was detected in breast tumors and was correlate... BeFree,CTD_human,GAD,LHGDN 25687182 Detail
0.208 Mammary Neoplasms Triple-negative breast cancer (TNBC) is a group of very aggressive breast tumour... BeFree,CTD_human,GAD,LHGDN 26112095 Detail
<0.001 Breast Cancer Model Herein, we probed estrogen receptor-α (ER) and progesterone receptor (PR) cross-... BeFree 24469035 Detail
<0.001 Mammary Tumorigenesis NA BeFree Detail
0.006 colorectal cancer NA BeFree,GAD Detail
<0.001 Ductal Breast Carcinoma Cyclin D1 expression was seen in 67.5% of ductal carcinoma and it showed a signi... BeFree 25313758 Detail
<0.001 Adenocarcinoma, Endometrioid Expression of OLFM4 was increased during endometrial carcinogenesis, linked to t... BeFree 24495253 Detail
<0.001 Adenocarcinoma, Endometrioid ECCCs had SCA-like features with rare expression of estrogen receptor/progestero... BeFree 25473756 Detail
<0.001 Endometrial Polyp NA BeFree Detail
<0.001 Apocrine Gland Carcinoma NA BeFree Detail
<0.001 Non-Neoplastic Disorder NA BeFree Detail
0.002 Meningioma, benign, no ICD-O subtype NA BeFree Detail
<0.001 Smith-McCort dysplasia NA BeFree Detail
0.003 Mammographic Density NA BeFree,GAD Detail
0.002 Progesterone Resistance NA BeFree Detail
<0.001 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1 NA BeFree Detail
0.002 Venous thromboembolism NA GAD Detail
<0.001 PANIC DISORDER 1 NA BeFree Detail
0.010 uterine corpus cancer Association of the +331G/A progesterone receptor gene (PgR) polymorphism with ri... BeFree 25037596 Detail
0.010 uterine corpus cancer Systematic dissection of the mechanisms underlying progesterone receptor downreg... BeFree 25229191 Detail
0.010 uterine corpus cancer A lentiviral-based shRNA knockdown approach was used to generate stable PGRMC1-i... BeFree 25304370 Detail
0.002 Proteinuria Adverse Event NA GAD Detail
<0.001 malignant neoplasm of breast staging NA BeFree Detail
<0.001 Endometrial sarcoma NA BeFree Detail
<0.001 Stage III Breast Cancer AJCC v7 NA BeFree Detail
<0.001 Progressive cGVHD NA BeFree Detail
0.016 Triple Negative Breast Neoplasms Triple-negative breast cancer (TNBC) is a distinct breast cancer subtype defined... BeFree 24786829 Detail
0.016 Triple Negative Breast Neoplasms There is no effective clinical therapy yet for triple-negative breast cancer (TN... BeFree 25016158 Detail
0.016 Triple Negative Breast Neoplasms Triple negative breast cancer (TNBC) and often basal-like cancers are defined as... BeFree 25100201 Detail
0.016 Triple Negative Breast Neoplasms Triple-negative breast cancer (TNBC) is defined by reduced expression of the est... BeFree 25212833 Detail
0.016 Triple Negative Breast Neoplasms Triple negative breast cancer (TNBC) is characterized by lack of expression of b... BeFree 25356777 Detail
0.016 Triple Negative Breast Neoplasms Particularly breast cancers, which do not express estrogen receptor α (ERα) and ... BeFree 25420519 Detail
0.016 Triple Negative Breast Neoplasms Here, we demonstrate that HIF expression and transcriptional activity are induce... BeFree 25453096 Detail
0.016 Triple Negative Breast Neoplasms Triple-negative breast cancer (TNBC) is an operational term that refers to a het... BeFree 25527230 Detail
0.016 Triple Negative Breast Neoplasms Triple-negative breast cancer (TNBC) is defined by the absence of expression of ... BeFree 25571912 Detail
0.016 Triple Negative Breast Neoplasms Triple negative breast cancer (TNBC) represents approximately 15% of breast canc... BeFree 25611337 Detail
0.016 Triple Negative Breast Neoplasms Positive immunostaining for USP2 was detected in breast tumors and was correlate... BeFree 25687182 Detail
0.016 Triple Negative Breast Neoplasms Triple negative breast cancer (TNBC) is a distinct breast cancer subtype, which ... BeFree 25748387 Detail
0.016 Triple Negative Breast Neoplasms Furthermore, whereas MEL-18 loss in luminal breast cancer cells resulted in the ... BeFree 25822021 Detail
0.016 Triple Negative Breast Neoplasms Single HR+ tumors without HER2 overexpression (ER + PR-HER2- or ER-PR + HER2-) w... BeFree 25880075 Detail
0.016 Triple Negative Breast Neoplasms We applied DERA to identify key regulations in triple negative breast cancer (TN... BeFree 25928379 Detail
0.016 Triple Negative Breast Neoplasms Triple-negative breast cancer (TNBC) is a group of very aggressive breast tumour... BeFree 26112095 Detail
0.016 Triple Negative Breast Neoplasms As a result of the 2010 American Society of Clinical Oncology (ASCO)/College of ... BeFree 26280679 Detail
<0.001 Basal-Like Breast Carcinoma NA BeFree Detail
0.002 Infection NA GAD Detail
<0.001 High grade serous carcinoma NA BeFree Detail
<0.001 Congenital Abnormality NA BeFree Detail
0.003 Spontaneous abortion NA LHGDN Detail
0.007 Abortion, Habitual NA GAD Detail
0.123 adenocarcinoma NA BeFree,CTD_human Detail
<0.001 adenoma NA BeFree Detail
<0.001 Adenovirus Infections NA BeFree Detail
<0.001 Anaplasia NA BeFree Detail
<0.001 aortic valve insufficiency Aromatase inhibitors (AIs) are the standard endocrine therapy for postmenopausal... BeFree 24413080 Detail
0.003 rheumatoid arthritis NA BeFree,GAD Detail
0.001 Astrocytoma PKCα and PKCδ activation regulates transcriptional activity and degradation of p... BeFree 25514083 Detail
0.002 Malignant neoplasm of urinary bladder NA GAD Detail
<0.001 Brain Neoplasms NA BeFree Detail
0.010 Malignant neoplasm of endometrium Association of the +331G/A progesterone receptor gene (PgR) polymorphism with ri... BeFree 25037596 Detail
0.010 Malignant neoplasm of endometrium Systematic dissection of the mechanisms underlying progesterone receptor downreg... BeFree 25229191 Detail
0.010 Malignant neoplasm of endometrium A lentiviral-based shRNA knockdown approach was used to generate stable PGRMC1-i... BeFree 25304370 Detail
<0.001 female breast carcinoma NA BeFree Detail
0.002 Noninfiltrating Intraductal Carcinoma NA BeFree Detail
<0.001 mucinous adenocarcinoma NA BeFree Detail
0.001 Non-small cell lung carcinoma NA BeFree Detail
Annotation

Annotations

DescrptionSourceLinks
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
CRISPLD2 is a target of progesterone receptor and its expression is decreased in women with endometr... DisGeNET Detail
Decreased expression of mucin-1 in endometriosis endometrium correlated with progesterone receptor B... DisGeNET Detail
Our results suggest that DNG exerts therapeutic efficacy against the pain and progression of endomet... DisGeNET Detail
Dienogest (DNG), a selective progesterone receptor agonist, is widely used to treat endometriosis an... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
We did not observe an association between potential functional genetic polymorphisms in the estrogen... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
ECCCs had SCA-like features with rare expression of estrogen receptor/progesterone receptor (18.8%/6... DisGeNET Detail
We did not observe an association between potential functional genetic polymorphisms in the estrogen... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Nuclear histological expression for ER-β was associated to sun-induced melasma and negative familiar... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
MTDH overexpression was significantly associated with a high nuclear grade, negative estrogen recept... DisGeNET Detail
Triple-negative breast cancer (TNBC) is a distinct breast cancer subtype defined by the absence of e... DisGeNET Detail
In breast cancer, PR becomes highly correlated with ER, and this convergence is associated with sign... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Importantly, this BTB mediated inhibition of ER activity is selective since BTB does not suppress th... DisGeNET Detail
NA DisGeNET Detail
Our results suggest that DNG exerts therapeutic efficacy against the pain and progression of endomet... DisGeNET Detail
NA DisGeNET Detail
Additionally, confirmation of immunoreactivity for progesterone receptor and pancreatic polypeptide ... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Progesterone receptor gene (PROGINS) polymorphism correlates with late onset of migraine. DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
In univariate analyses, high tumor cell density (p = 0.006) and high tumor stromal cell density leve... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Expression of OLFM4 was increased during endometrial carcinogenesis, linked to the differentiation o... DisGeNET Detail
ECCCs had SCA-like features with rare expression of estrogen receptor/progesterone receptor (18.8%/6... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Additionally, confirmation of immunoreactivity for progesterone receptor and pancreatic polypeptide ... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Impact of estrogen and progesterone receptor expression on the clinical and molecular features of pa... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
This phenomenon is regulated through an interaction between SMTNL1 and progesterone receptor, which ... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
PLC was associated more closely with in situ carcinoma (P = .03), and had lower progesterone recepto... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
High progesterone receptor expression in prostate cancer is associated with clinical failure. DisGeNET Detail
NA DisGeNET Detail
Association of the +331G/A progesterone receptor gene (PgR) polymorphism with risk of endometrial ca... DisGeNET Detail
Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometri... DisGeNET Detail
A lentiviral-based shRNA knockdown approach was used to generate stable PGRMC1-intact and PGRMC1-dep... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Glyoxalase I Ala111Glu gene polymorphism: No association with breast cancer risk but correlated with... DisGeNET Detail
Glyoxalase I Ala111Glu gene polymorphism: No association with breast cancer risk but correlated with... DisGeNET Detail
Progesterone, acting through its receptor, PR (progesterone receptor), is the natural inhibitor of u... DisGeNET Detail
Loss of miR-141 enhanced both mammosphere formation and tumor initiation. miR-141 directly targeted ... DisGeNET Detail
High progesterone receptor expression in prostate cancer is associated with clinical failure. DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
The overall analysis showed that higher expression of ALDH1A1 is associated with larger tumor size, ... DisGeNET Detail
In addition, significant associations were also observed between TNFRSF1A polymorphisms and lymph no... DisGeNET Detail
LOH in THRB was associated with negative estrogen receptor (ER), negative progesterone receptor (PR)... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Higher miR-21 expression in invasive breast carcinomas is associated with positive estrogen and prog... DisGeNET Detail
Aberrant events and increased variation in imprinted gene DNA methylation, therefore, seem to be fre... DisGeNET Detail
NA DisGeNET Detail
In univariate analyses, high tumor cell density (p = 0.006) and high tumor stromal cell density leve... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
We analyzed the changes in mitochondrial DNA (mtDNA) copy numbers and the shifting of mtDNA D310 seq... DisGeNET Detail
Importantly, this BTB mediated inhibition of ER activity is selective since BTB does not suppress th... DisGeNET Detail
NA DisGeNET Detail
Cyclin D1 expression was seen in 67.5% of ductal carcinoma and it showed a significant correlation w... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Our study showed that PanNETs with favorable prognostic features have higher ERβ expression, which i... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
A model of spontaneous mouse mammary tumor for human estrogen receptor- and progesterone receptor-ne... DisGeNET Detail
Progesterone receptor activation downregulates GATA3 by transcriptional repression and increased pro... DisGeNET Detail
Positive immunostaining for USP2 was detected in breast tumors and was correlated with estrogen rece... DisGeNET Detail
Triple-negative breast cancer (TNBC) is a group of very aggressive breast tumours, characterised by ... DisGeNET Detail
Herein, we probed estrogen receptor-α (ER) and progesterone receptor (PR) cross-talk in breast cance... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Cyclin D1 expression was seen in 67.5% of ductal carcinoma and it showed a significant correlation w... DisGeNET Detail
Expression of OLFM4 was increased during endometrial carcinogenesis, linked to the differentiation o... DisGeNET Detail
ECCCs had SCA-like features with rare expression of estrogen receptor/progesterone receptor (18.8%/6... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Association of the +331G/A progesterone receptor gene (PgR) polymorphism with risk of endometrial ca... DisGeNET Detail
Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometri... DisGeNET Detail
A lentiviral-based shRNA knockdown approach was used to generate stable PGRMC1-intact and PGRMC1-dep... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Triple-negative breast cancer (TNBC) is a distinct breast cancer subtype defined by the absence of e... DisGeNET Detail
There is no effective clinical therapy yet for triple-negative breast cancer (TNBC) without particul... DisGeNET Detail
Triple negative breast cancer (TNBC) and often basal-like cancers are defined as negative for estrog... DisGeNET Detail
Triple-negative breast cancer (TNBC) is defined by reduced expression of the estrogen receptor, prog... DisGeNET Detail
Triple negative breast cancer (TNBC) is characterized by lack of expression of both estrogen and pro... DisGeNET Detail
Particularly breast cancers, which do not express estrogen receptor α (ERα) and progesterone recepto... DisGeNET Detail
Here, we demonstrate that HIF expression and transcriptional activity are induced by treatment of MD... DisGeNET Detail
Triple-negative breast cancer (TNBC) is an operational term that refers to a heterogeneous collectio... DisGeNET Detail
Triple-negative breast cancer (TNBC) is defined by the absence of expression of the estrogen recepto... DisGeNET Detail
Triple negative breast cancer (TNBC) represents approximately 15% of breast cancers and is character... DisGeNET Detail
Positive immunostaining for USP2 was detected in breast tumors and was correlated with estrogen rece... DisGeNET Detail
Triple negative breast cancer (TNBC) is a distinct breast cancer subtype, which is defined by the ab... DisGeNET Detail
Furthermore, whereas MEL-18 loss in luminal breast cancer cells resulted in the downregulation of ex... DisGeNET Detail
Single HR+ tumors without HER2 overexpression (ER + PR-HER2- or ER-PR + HER2-) were associated with ... DisGeNET Detail
We applied DERA to identify key regulations in triple negative breast cancer (TNBC), which is charac... DisGeNET Detail
Triple-negative breast cancer (TNBC) is a group of very aggressive breast tumours, characterised by ... DisGeNET Detail
As a result of the 2010 American Society of Clinical Oncology (ASCO)/College of American Pathologist... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Aromatase inhibitors (AIs) are the standard endocrine therapy for postmenopausal breast cancer; howe... DisGeNET Detail
NA DisGeNET Detail
PKCα and PKCδ activation regulates transcriptional activity and degradation of progesterone receptor... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Association of the +331G/A progesterone receptor gene (PgR) polymorphism with risk of endometrial ca... DisGeNET Detail
Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometri... DisGeNET Detail
A lentiviral-based shRNA knockdown approach was used to generate stable PGRMC1-intact and PGRMC1-dep... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
dbSNP
rs386572987 dbSNP
Genome
hg38
Position
chr11:101,029,624-101,129,813
Variant Type
snv
Genome browser